| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GLAUKOS CORP | 2,586,985 | 75,436,483 | 76.45% | ||
| 2 | OCULAR THERAPEUTIX INC | 2,215,384 | 10,966,151 | 11.11% | ||
| 3 | CLOVIS ONCOLOGY INC | 407,416 | 5,589,748 | 5.66% | ||
| 4 | ACHAOGEN INC COM | 1,281,152 | 4,855,566 | 4.92% | ||
| 5 | CymaBay Therapeutics | 1,048,601 | 1,824,566 | 1.85% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-135018, filed 2016.07.28).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
